World Journal of Oncology

recept

resep masakan indonesia
resep masakan indonesia
delicious recipe

Editor-in-Chief
Michael G. Martin, MD, Associate Professor of Medicine, West Cancer Center, Univ. of Tennessee, USA. More...

Frequency: Bimonthly
Journal Access: Open Access

ISSN-print: 1920-4531

ISSN-online: 1920-454X
Indexed and covered: Chemical Abstracts (CA); JournalTOCs; Google Scholar; Elsevier EMBASE; EBSCO; Worldcat; Clarivate Analytics Links- Journal Title List; PubMed Central; PubMed; Scopus, Web of Science (ESCI).
Journal archiving and digital preservation: Portico


Special Issue--call for submissions

COVID-19 in Low Income Countries
COVID-19 has presented novel challenges to health care systems across the world. We at the World Journal of Oncology would like to take a deeper dive into the interaction of COVID-19 and cancer patients across the world. Specifically we are soliciting articles from authors in low income countries. Submission for this special issue with be accepted through October 1st with publication expected on December 1st, 2020. All author fees will be reduced by 50% for this issue. Thank you and we look forward to your submissions. Michael G. Martin, Editor-in-Chief.

 

Highlights

  • Fluorescence Emitted by Papanicolaou-Stained Urothelial Cells Improves Sensitivity of Urinary Conventional Cytology for Detection of Urothelial Tumors

    Urinary conventional cytology (UCCy) is easy to perform, but its low sensitivity, especially for low-grade urothelial neoplasms (LGUNs), limits its indications in the management of patients at risk of bladder cancer.

    Read More >>
  • Morphology of Tissue Disruption at Sites of High-Grade Tumors

    Invasive solid cancers originating from diverse organs like breast, ovary and lung metastasize to distant sites. The structural changes at the primary sites of these high-grade tumors have not been well characterized.

    Read More >>
  • Epidemiology of Renal Cell Carcinoma

    Though renal cell carcinoma (RCC) accounts for 2% of global cancer diagnoses and deaths, it has more than doubled in incidence in the developed world over the past half-century, and today is the ninth most common neoplasm in the United States (US).

    Read More >>
  • Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer

    This study aimed to investigate the association of computed tomography (CT)-assessed sarcopenia and visceral adiposity with efficacy and prognosis of immune-checkpoint inhibitor (ICI) therapy for pretreated non-small cell lung cancer (NSCLC).

    Read More >>
  • Recent Advances in the Management of Smoldering Multiple Myeloma

    There is remarkable progress in the treatment of multiple myeloma (MM) with significant improvement in survival in the past 10 years. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) can evolve into symptomatic multiple myeloma (sy-MM) with organ involvement.

    Read More >>

View Points

 

 

Featured

 

Recent Advances in the Management of Smoldering Multiple Myeloma
There is remarkable progress in the treatment of multiple myeloma (MM) with significant improvement in survival in the past 10 years. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) can evolve into symptomatic multiple myeloma (sy-MM) with organ involvement. Full Text

Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) (represents roughly 25% of all breast cancers in Yogyakarta) still has the worst survival compared to other breast cancer subtypes. Results from recent studies have shown that inhibition of programmed death-ligand 1 receptor (PD-L1) in TNBC patients is associated with better prognosis. Full Text




Image of the Issue

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
This case implies that although mogamulizumab has efficacy against T cell lymphomas, the off-target effects of mogamulizumab on T cells normally involved in immune surveillance against virally infected cells can lead to the selective emergence of EBV-positive DLBCL. Administration of this medication requires careful monitoring and surveillance to detect emerging infections and lymphomas. Full Text


Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.


Current Issue

 


Vol. 11, No. 5, Oct 2020

Table of Contents

Review

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors Abstract HTML PDF
Ragia Aly, Amandeep S. Aujla, Sachin Gupta, Ruby Gupta, Sorab Gupta, Sheila Kalathil 183-187
doi: https://doi.org/10.14740/wjon1325

Original Article

Clinicopathologic Features and Survival Trends for Acinic Cell Carcinoma of the Major Salivary Glands: A Surveillance, Epidemiology, and End Results Population Analysis Abstract HTML PDF
Erin A. Kaya, Zachary C. Taylor, Brian J. Mitchell, Zachary D. Guss, Jeffrey D. Bunn, Robert K. Fairbanks, Wayne T. Lamoreaux, Aaron E. Wagner, Ben J. Peressini, Christopher M. Lee 188-196
doi: https://doi.org/10.14740/wjon1312
Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial Abstract HTML PDF
Takanori Kin, Shoichiro Ohtani, Reina Maeda, Ayako Ueno, Miwa Fujihara, Yuri Takamatsu, Yukiko Kajiwara, Mitsuya Ito, Kensuke Kawasaki, Keisuke Abe, Yasuhiko Sakata, Koichi Hiraki 197-203
doi: https://doi.org/10.14740/wjon1333
Fluorescence Emitted by Papanicolaou-Stained Urothelial Cells Improves Sensitivity of Urinary Conventional Cytology for Detection of Urothelial Tumors Abstract HTML PDF
Kinan Drak Alsibai, Ghislaine Daste, Sophie Ferlicot, Monique Fabre, Karine Steenkeste, Julia Salleron, Yacine Hammoudi, Marie-Pierre Fontaine-Aupart, Pascal Eschwege 204-215
doi: https://doi.org/10.14740/wjon1305
Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer Abstract HTML PDF Suppl1
Ibnu Purwanto, Didik Setyo Heriyanto, Ahmad Ghozali, Irianiwati Widodo, Iwan Dwiprahasto, Teguh Aryandono, Sofia Mubarika Haryana 216-222
doi: https://doi.org/10.14740/wjon1302
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

World Journal of Oncology, bimonthly, ISSN 1920-4531 (print), 1920-454X (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.wjon.org   editorial contact: editor@wjon.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.